��������

Evgueni Neiman is a skilled statistical programmer with extensive experience across various roles in the biotechnology and clinical research fields. Currently serving as a Senior Statistical Programmer II at Exelixis since October 2021, Evgueni leads complex Phase 1 ADC trials and focuses on drug safety analyses. Prior experience includes a tenure at Emergent BioSolutions where Evgueni established company-wide programming standards and managed multiple studies, as well as a role at Everest Clinical Research performing quality checks and statistical analyses. Evgueni has also contributed to notable publications, including co-authoring a study on Cystic Fibrosis. Academic credentials include a Master's Degree in Statistics from the University of Cincinnati and a Bachelor's Degree in Actuarial Science from Ohio University.